BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Sirona Biochem To Present Kel-01 At Cosmetic 360 In Paris, France

  Sirona Biochem Corp. announced that Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy, will attend and present on the trade floor at Cosmetic 360 in Paris, France on October 18-19, 2017.

  October 16, 2017

   · 

  2 min read
• 

  BioCapital

  Intrexon Enters Into $100M Preferred Stock Equity Facility

  Intrexon today announced that it has entered into a Preferred Stock Equity Facility with an affiliate of Third Security.

  October 16, 2017

   · 

  3 min read
• Drug Development

  PROMETRIKA To Coordinate Second Phase I Trial For MD Anderson’s Institute For Applied Cancer Science

  PROMETRIKA, LLC, a boutique full service Clinical Research Organization (CRO), is coordinating a Phase 1 trial for The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science.

  October 16, 2017

   · 

  1 min read
• Business

  Applied BioMath, LLC announces collaboration with Sanofi for quantitative systems pharmacology modeling in immuno-oncology

  Applied BioMath today announced a collaboration with Sanofi to develop QSP models in immuno-oncology.

  October 16, 2017

   · 

  2 min read
• Drug Development

  Atara Biotherapeutics Announces Abstract Publication for Two MSParis2017 Congress Presentations, Including Updated Interim Results from a Phase I Study of Autologous ATA190 in Patients with Progressive MS

  Five of eight progressive MS patients who received the full course of autologous ATA190 experienced clinical improvements.

  October 16, 2017

   · 

  8 min read
• Drug Development

  Cognition Therapeutics Receives Fast Track Designation from U.S. FDA for First-in-Class Alzheimer’s Candidate, CT1812

  Cognition announced that the FDA has granted Fast Track designation to its investigational drug CT1812 for the treatment of patients with Alzheimer’s disease.

  October 16, 2017

   · 

  3 min read
• 

  Job Trends

  Mallinckrodt Created 330 New Jobs With Specialty Brands Office In NJ

  The new office is home to nearly 500 Jobs supporting the company’s hospital therapies and autoimmune and rare diseases businesses.

  October 16, 2017

   · 

  5 min read
• Business

  Poxel Announces Third Quarter 2017 Financial Update

  POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced today its cash position for the third quarter of 2017.

  October 16, 2017

   · 

  3 min read
• Biotech Bay

  IGeneX Inc. Introduces New Diagnostic Tests for Lyme Disease and Tick-Borne Relapsing Fever

  IGeneX Inc. announce the launch of three new tests that are more inclusive and specific for aiding in diagnosis of Borreliosis (Lyme Disease and Tick-Borne Relapsing Fever, Borreliosis).

  October 16, 2017

   · 

  3 min read
• Genetown

  Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants

  ConforMIS has obtained additional positive clinical data regarding the performance of its customized partial knee replacement implants.

  October 16, 2017

   · 

  5 min read